Michael S. Weiss

2012 - TG Therapeutics

In 2012, Michael S. Weiss earned a total compensation of $11.2M as Executive Chairman, Interim Chief Executive Officer and President at TG Therapeutics, a 399% increase compared to previous year.

Compensation breakdown

Salary$225,000
Stock Awards$11,003,601
Total$11,228,601

Weiss received $11M in stock awards, accounting for 98% of the total pay in 2012.

Weiss also received $225K in salary.

Rankings

In 2012, Michael S. Weiss' compensation ranked 341st out of 11,487 executives tracked by ExecPay. In other words, Weiss earned more than 97.0% of executives.

ClassificationRankingPercentile
All
341
out of 11,487
97th
Division
Manufacturing
128
out of 4,253
97th
Major group
Chemicals And Allied Products
26
out of 1,203
98th
Industry group
Drugs
13
out of 925
99th
Industry
Pharmaceutical Preparations
10
out of 700
99th
Source: SEC filing on April 24, 2013.

Weiss' colleagues

We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2012.

2012

Sean Power

TG Therapeutics

Chief Financial Officer

News

You may also like